Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30402594 | 0.81 | CA4 (0.39) | CA4 | |
| SCHEMBL31121005 | 0.81 | CA4 (0.39) | CA4BBOX1 | |
| SCHEMBL29540929 | 0.79 | CA4 (0.38) | CA4BBOX1 | |
| SCHEMBL30758921 | 0.78 | CA4 (0.37) | CA4BBOX1 | |
| SCHEMBL30160923 | 0.77 | CA4 (0.46) | CA4BBOX1 | |
| SCHEMBL29497518 | 0.77 | CA4 (0.46) | CA4BBOX1 | |
| SCHEMBL31596793 | 0.76 | CA4 (0.35) | CA4BBOX1 | |
| Hydrochloric Acid SCHEMBL31574660 | 0.76 | CA4 (0.45) | CA4 | |
| Hydrochloric Acid SCHEMBL30446529 | 0.76 | CA4 (0.45) | CA4 | |
| SCHEMBL31046982 | 0.74 | CA4 (0.43) | CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3244878-B1 | SOLID ORAL DOSAGE FORMS | ENTERIS BIOPHARMA INC (US) | 2022-08-10 | — | — | EP | claimed |
| EP-4685483-A1 | SPHINGOLIPID METABOLIC MARKER, ANALYSIS METHOD THEREFOR AND USE THEREOF | China-Japan Friendship Hospital (China-Japan Friendship Institute of Clinical Medicine) (CN) | 2026-01-28 | — | — | EP | disclosed |
| CN-114878723-B | Metabolic marker for rapidly diagnosing multiple myeloma and application thereof | 中日友好医院(中日友好临床医学研究所) | 2022-09-23 | — | — | CN | disclosed |
| CN-114878723-A | Metabolism marker for rapidly diagnosing multiple myeloma and application thereof | 中日友好医院(中日友好临床医学研究所) | 2022-08-09 | — | — | CN | disclosed |